Response to: Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al

John H. Stone, Mollie N. Carruthers, Mark Topazian, Arezou Khosroshahi, Thomas Elmer Witzig, Zachary S. Wallace, Phillip A. Hart, Vikram Deshpande, Thomas Christopher Smyrk, Suresh T Chari

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Article numberA34
JournalAnnals of the Rheumatic Diseases
Volume74
Issue number8
DOIs
StatePublished - Aug 1 2015

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

Response to : Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. / Stone, John H.; Carruthers, Mollie N.; Topazian, Mark; Khosroshahi, Arezou; Witzig, Thomas Elmer; Wallace, Zachary S.; Hart, Phillip A.; Deshpande, Vikram; Smyrk, Thomas Christopher; Chari, Suresh T.

In: Annals of the Rheumatic Diseases, Vol. 74, No. 8, A34, 01.08.2015.

Research output: Contribution to journalArticle

Stone, John H. ; Carruthers, Mollie N. ; Topazian, Mark ; Khosroshahi, Arezou ; Witzig, Thomas Elmer ; Wallace, Zachary S. ; Hart, Phillip A. ; Deshpande, Vikram ; Smyrk, Thomas Christopher ; Chari, Suresh T. / Response to : Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. In: Annals of the Rheumatic Diseases. 2015 ; Vol. 74, No. 8.
@article{069fec029ddc4a13bc74ff4f0435500e,
title = "Response to: Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al",
author = "Stone, {John H.} and Carruthers, {Mollie N.} and Mark Topazian and Arezou Khosroshahi and Witzig, {Thomas Elmer} and Wallace, {Zachary S.} and Hart, {Phillip A.} and Vikram Deshpande and Smyrk, {Thomas Christopher} and Chari, {Suresh T}",
year = "2015",
month = "8",
day = "1",
doi = "10.1136/annrheumdis-2015-207640",
language = "English (US)",
volume = "74",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Response to

T2 - Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al

AU - Stone, John H.

AU - Carruthers, Mollie N.

AU - Topazian, Mark

AU - Khosroshahi, Arezou

AU - Witzig, Thomas Elmer

AU - Wallace, Zachary S.

AU - Hart, Phillip A.

AU - Deshpande, Vikram

AU - Smyrk, Thomas Christopher

AU - Chari, Suresh T

PY - 2015/8/1

Y1 - 2015/8/1

UR - http://www.scopus.com/inward/record.url?scp=84940104761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940104761&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2015-207640

DO - 10.1136/annrheumdis-2015-207640

M3 - Article

C2 - 26160908

AN - SCOPUS:84940104761

VL - 74

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 8

M1 - A34

ER -